[1]
Muhummad Nasir Rahman and M. Javed, “Tirofiban and Rivaroxaban use in the management of right coronary artery thrombus as a primary manifestation of essential thrombocythemia”, J Pak Med Assoc, vol. 72, no. 3, Feb. 2022.